You have read all your free articles, to continue reading subscribe to read the rest of this content.
Swedish pharmaceutical company LIDDS has appointed Nina Herne as its new CEO. LIDDS has developed a drug delivery technology, NanoZolid, which provides a controlled and sustained release of active drug substances for up to six months. The GMP manufacturing process is based on nano-crystallizationAlready a subscriber Login You have read…
Getting back to work after a long and relaxing holiday can be quite hard, here is some advice to make things easier and make your return less stress-free. 1. Plan your return Most people focus on getting organized for departure, perhaps maximizing their time away and then comes home just…
Nordic Life Science Magazine had an exclusive interview with Jim Van heusden, the new CEO of Karolinska Development. 7842Already a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content.…
InDex Pharmaceuticals recently announced conclusions from its CONDUCT study, evaluating their TLR9 agonist cobitolimod for the treatment of moderate to severe ulcerative colitis. Congratulations to the positive results from the CONDUCT study. What are the next steps and when can we expect additioAlready a subscriber Login You have read all…
